Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
Open Access
- 1 January 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 8 (6), R182
- https://doi.org/10.1186/ar2093
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamideNature Clinical Practice Nephrology, 2006
- Why Most Published Research Findings Are FalsePLoS Medicine, 2005
- Preventing renal failure in patients with severe lupus nephritisKidney International, 2005
- Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre‐transplant diabetesClinical Transplantation, 2005
- Maintenance Therapies for Proliferative Lupus Nephritis: Mycophenolate Mofetil, Azathioprine and Intravenous CyclophosphamideLupus, 2005
- Lupus Nephritis: Induction TherapyLupus, 2005
- Lupus Nephritis: Induction TherapyLupus, 2005
- An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient dataPain, 2000
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996